Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 11 of 11 entries
Sorted by: Best Match Show Resources per page
Recurrence of Graves' Disease: What Genetics of HLA and .

Frontiers in endocrinology

Vejrazkova D, Vcelak J, Vaclavikova E, Vankova M, Zajickova K, Vrbikova J, Duskova M, Pacesova P, Novak Z, Bendlova B.
PMID: 34887833
Front Endocrinol (Lausanne). 2021 Nov 23;12:761077. doi: 10.3389/fendo.2021.761077. eCollection 2021.

BACKGROUND: Approximately half of patients diagnosed with Graves' disease (GD) relapse within two years of thyreostatic drug withdrawal. It is then necessary to decide whether to reintroduce conservative treatment that can have serious side effects, or to choose a...

Cite
Vejrazkova D, Vcelak J, Vaclavikova E, et al. Recurrence of Graves' Disease: What Genetics of HLA and . Front Endocrinol (Lausanne). 2021;12:761077doi: 10.3389/fendo.2021.761077.
Vejrazkova, D., Vcelak, J., Vaclavikova, E., Vankova, M., Zajickova, K., Vrbikova, J., Duskova, M., Pacesova, P., Novak, Z., & Bendlova, B. (2021). Recurrence of Graves' Disease: What Genetics of HLA and . Frontiers in endocrinology, 12761077. https://doi.org/10.3389/fendo.2021.761077
Vejrazkova, Daniela, et al. "Recurrence of Graves' Disease: What Genetics of HLA and ." Frontiers in endocrinology vol. 12 (2021): 761077. doi: https://doi.org/10.3389/fendo.2021.761077
Vejrazkova D, Vcelak J, Vaclavikova E, Vankova M, Zajickova K, Vrbikova J, Duskova M, Pacesova P, Novak Z, Bendlova B. Recurrence of Graves' Disease: What Genetics of HLA and . Front Endocrinol (Lausanne). 2021 Nov 23;12:761077. doi: 10.3389/fendo.2021.761077. eCollection 2021. PMID: 34887833; PMCID: PMC8650699.
Copy Download .nbib Format: NLM
The relationship between adolescent obesity and pelvis dimensions in adulthood: a retrospective longitudinal study.

PeerJ

Novak JM, Bruzek J, Zamrazilova H, Vankova M, Hill M, Sedlak P.
PMID: 32435530
PeerJ. 2020 May 11;8:e8951. doi: 10.7717/peerj.8951. eCollection 2020.

BACKGROUND: The effect of fat tissue on a developing individual is fundamentally different from the effect on an adult. Several changes caused by obesity during sexual maturation have an irreversible and severe negative effect (lower fertility, reduced final height,...

Cite
Novak JM, Bruzek J, Zamrazilova H, et al. The relationship between adolescent obesity and pelvis dimensions in adulthood: a retrospective longitudinal study. PeerJ. 2020;8:e8951doi: 10.7717/peerj.8951.
Novak, J. M., Bruzek, J., Zamrazilova, H., Vankova, M., Hill, M., & Sedlak, P. (2020). The relationship between adolescent obesity and pelvis dimensions in adulthood: a retrospective longitudinal study. PeerJ, 8e8951. https://doi.org/10.7717/peerj.8951
Novak, Jan M, et al. "The relationship between adolescent obesity and pelvis dimensions in adulthood: a retrospective longitudinal study." PeerJ vol. 8 (2020): e8951. doi: https://doi.org/10.7717/peerj.8951
Novak JM, Bruzek J, Zamrazilova H, Vankova M, Hill M, Sedlak P. The relationship between adolescent obesity and pelvis dimensions in adulthood: a retrospective longitudinal study. PeerJ. 2020 May 11;8:e8951. doi: 10.7717/peerj.8951. eCollection 2020. PMID: 32435530; PMCID: PMC7224231.
Copy Download .nbib Format: NLM
Efficacy and Safety of Procalcitonin Guidance in Patients With Suspected or Confirmed Sepsis: A Systematic Review and Meta-Analysis: Author Correction.

Critical care medicine

Claxton AJ, Thompson-Leduc P, Kirson NY, Rice B, Hey J, Iankova I, Krause A, Schonfeld SA, DeBrase CR, Bozzette S, Schuetz P.
PMID: 30113378
Crit Care Med. 2018 Sep;46(9):1560. doi: 10.1097/CCM.0000000000003308.

No abstract available.

Cite
Claxton AJ, Thompson-Leduc P, Kirson NY, et al. Efficacy and Safety of Procalcitonin Guidance in Patients With Suspected or Confirmed Sepsis: A Systematic Review and Meta-Analysis: Author Correction. Crit Care Med. 2018;46(9):1560doi: 10.1097/CCM.0000000000003308.
Claxton, A. J., Thompson-Leduc, P., Kirson, N. Y., Rice, B., Hey, J., Iankova, I., Krause, A., Schonfeld, S. A., DeBrase, C. R., Bozzette, S., & Schuetz, P. (2018). Efficacy and Safety of Procalcitonin Guidance in Patients With Suspected or Confirmed Sepsis: A Systematic Review and Meta-Analysis: Author Correction. Critical care medicine, 46(9), 1560. https://doi.org/10.1097/CCM.0000000000003308
Claxton, Ami J, et al. "Efficacy and Safety of Procalcitonin Guidance in Patients With Suspected or Confirmed Sepsis: A Systematic Review and Meta-Analysis: Author Correction." Critical care medicine vol. 46,9 (2018): 1560. doi: https://doi.org/10.1097/CCM.0000000000003308
Claxton AJ, Thompson-Leduc P, Kirson NY, Rice B, Hey J, Iankova I, Krause A, Schonfeld SA, DeBrase CR, Bozzette S, Schuetz P. Efficacy and Safety of Procalcitonin Guidance in Patients With Suspected or Confirmed Sepsis: A Systematic Review and Meta-Analysis: Author Correction. Crit Care Med. 2018 Sep;46(9):1560. doi: 10.1097/CCM.0000000000003308. PMID: 30113378.
Copy Download .nbib Format: NLM
Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders.

Frontiers in neurology

Iankova V, Karin I, Klopstock T, Schneider SA.
PMID: 33935938
Front Neurol. 2021 Apr 15;12:629414. doi: 10.3389/fneur.2021.629414. eCollection 2021.

Neurodegeneration with Brain Iron Accumulation (NBIA) is a heterogeneous group of progressive neurodegenerative diseases characterized by iron deposition in the globus pallidus and the substantia nigra. As of today, 15 distinct monogenetic disease entities have been identified. The four...

Cite
Iankova V, Karin I, Klopstock T, et al. Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders. Front Neurol. 2021;12:629414doi: 10.3389/fneur.2021.629414.
Iankova, V., Karin, I., Klopstock, T., & Schneider, S. A. (2021). Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders. Frontiers in neurology, 12629414. https://doi.org/10.3389/fneur.2021.629414
Iankova, Vassilena, et al. "Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders." Frontiers in neurology vol. 12 (2021): 629414. doi: https://doi.org/10.3389/fneur.2021.629414
Iankova V, Karin I, Klopstock T, Schneider SA. Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders. Front Neurol. 2021 Apr 15;12:629414. doi: 10.3389/fneur.2021.629414. eCollection 2021. PMID: 33935938; PMCID: PMC8082061.
Copy Download .nbib Format: NLM
Recurrence of Graves' Disease: What Genetics of HLA and .

Frontiers in endocrinology

Vejrazkova D, Vcelak J, Vaclavikova E, Vankova M, Zajickova K, Vrbikova J, Duskova M, Pacesova P, Novak Z, Bendlova B.
PMID: 34887833
Front Endocrinol (Lausanne). 2021 Nov 23;12:761077. doi: 10.3389/fendo.2021.761077. eCollection 2021.

BACKGROUND: Approximately half of patients diagnosed with Graves' disease (GD) relapse within two years of thyreostatic drug withdrawal. It is then necessary to decide whether to reintroduce conservative treatment that can have serious side effects, or to choose a...

Cite
Vejrazkova D, Vcelak J, Vaclavikova E, et al. Recurrence of Graves' Disease: What Genetics of HLA and . Front Endocrinol (Lausanne). 2021;12:761077doi: 10.3389/fendo.2021.761077.
Vejrazkova, D., Vcelak, J., Vaclavikova, E., Vankova, M., Zajickova, K., Vrbikova, J., Duskova, M., Pacesova, P., Novak, Z., & Bendlova, B. (2021). Recurrence of Graves' Disease: What Genetics of HLA and . Frontiers in endocrinology, 12761077. https://doi.org/10.3389/fendo.2021.761077
Vejrazkova, Daniela, et al. "Recurrence of Graves' Disease: What Genetics of HLA and ." Frontiers in endocrinology vol. 12 (2021): 761077. doi: https://doi.org/10.3389/fendo.2021.761077
Vejrazkova D, Vcelak J, Vaclavikova E, Vankova M, Zajickova K, Vrbikova J, Duskova M, Pacesova P, Novak Z, Bendlova B. Recurrence of Graves' Disease: What Genetics of HLA and . Front Endocrinol (Lausanne). 2021 Nov 23;12:761077. doi: 10.3389/fendo.2021.761077. eCollection 2021. PMID: 34887833; PMCID: PMC8650699.
Copy Download .nbib Format: NLM
MTNR1B Genetic Variability Is Associated with Gestational Diabetes in Czech Women.

International journal of endocrinology

Vejrazkova D, Lukasova P, Vankova M, Vcelak J, Bradnova O, Cirmanova V, Andelova K, Krejci H, Bendlova B.
PMID: 25132852
Int J Endocrinol. 2014;2014:508923. doi: 10.1155/2014/508923. Epub 2014 Jul 15.

The gene MTNR1B encodes a receptor for melatonin. Melatonin receptors are expressed in human β-cells, which implies that genetic variants might affect glucose tolerance. Meta-analysis confirmed that the rs10830963 shows the most robust association. The aim of the study...

Cite
Vejrazkova D, Lukasova P, Vankova M, et al. MTNR1B Genetic Variability Is Associated with Gestational Diabetes in Czech Women. Int J Endocrinol. 2014;2014:508923doi: 10.1155/2014/508923.
Vejrazkova, D., Lukasova, P., Vankova, M., Vcelak, J., Bradnova, O., Cirmanova, V., Andelova, K., Krejci, H., & Bendlova, B. (2014). MTNR1B Genetic Variability Is Associated with Gestational Diabetes in Czech Women. International journal of endocrinology, 2014508923. https://doi.org/10.1155/2014/508923
Vejrazkova, Daniela, et al. "MTNR1B Genetic Variability Is Associated with Gestational Diabetes in Czech Women." International journal of endocrinology vol. 2014 (2014): 508923. doi: https://doi.org/10.1155/2014/508923
Vejrazkova D, Lukasova P, Vankova M, Vcelak J, Bradnova O, Cirmanova V, Andelova K, Krejci H, Bendlova B. MTNR1B Genetic Variability Is Associated with Gestational Diabetes in Czech Women. Int J Endocrinol. 2014;2014:508923. doi: 10.1155/2014/508923. Epub 2014 Jul 15. PMID: 25132852; PMCID: PMC4123535.
Copy Download .nbib Format: NLM
Lanthanide Complexes of the alpha-1 Isomer of the [P(2)W(17)O(61)](10-) Heteropolytungstate: Preparation, Stoichiometry, and Structural Characterization by (183)W and (31)P NMR Spectroscopy and Europium(III) Luminescence Spectroscopy.

Inorganic chemistry

Bartis J, Dankova M, Lessmann JJ, Luo QH, Horrocks WD, Francesconi LC.
PMID: 11670884
Inorg Chem. 1999 Mar 22;38(6):1042-1053. doi: 10.1021/ic980384i.

The alpha-1 and alpha-2 [P(2)W(17)O(61)](10)(-) isomers, derivatives of the Wells-Dawson molecule, [alpha-P(2)W(18)O(62)](6)(-), may be useful ligands for stabilizing high-valent metal ions and lanthanides and actinides. However, the potential utility of the [alpha1-P(2)W(17)O(61)](10)(-) ligand has not been realized. Specifically, for...

Cite
Bartis J, Dankova M, Lessmann JJ, et al. Lanthanide Complexes of the alpha-1 Isomer of the [P(2)W(17)O(61)](10-) Heteropolytungstate: Preparation, Stoichiometry, and Structural Characterization by (183)W and (31)P NMR Spectroscopy and Europium(III) Luminescence Spectroscopy. Inorg Chem. 1999;38(6):1042-1053doi: 10.1021/ic980384i.
Bartis, J., Dankova, M., Lessmann, J. J., Luo, Q. H., Horrocks, W. D., & Francesconi, L. C. (1999). Lanthanide Complexes of the alpha-1 Isomer of the [P(2)W(17)O(61)](10-) Heteropolytungstate: Preparation, Stoichiometry, and Structural Characterization by (183)W and (31)P NMR Spectroscopy and Europium(III) Luminescence Spectroscopy. Inorganic chemistry, 38(6), 1042-1053. https://doi.org/10.1021/ic980384i
Bartis, Judit, et al. "Lanthanide Complexes of the alpha-1 Isomer of the [P(2)W(17)O(61)](10-) Heteropolytungstate: Preparation, Stoichiometry, and Structural Characterization by (183)W and (31)P NMR Spectroscopy and Europium(III) Luminescence Spectroscopy." Inorganic chemistry vol. 38,6 (1999): 1042-1053. doi: https://doi.org/10.1021/ic980384i
Bartis J, Dankova M, Lessmann JJ, Luo QH, Horrocks WD, Francesconi LC. Lanthanide Complexes of the alpha-1 Isomer of the [P(2)W(17)O(61)](10-) Heteropolytungstate: Preparation, Stoichiometry, and Structural Characterization by (183)W and (31)P NMR Spectroscopy and Europium(III) Luminescence Spectroscopy. Inorg Chem. 1999 Mar 22;38(6):1042-1053. doi: 10.1021/ic980384i. PMID: 11670884.
Copy Download .nbib Format: NLM
Analysis of killing of growing cells and dormant and germinated spores of Bacillus species by black silicon nanopillars.

Scientific reports

Ghosh S, Niu S, Yankova M, Mecklenburg M, King SM, Ravichandran J, Kalia RK, Nakano A, Vashishta P, Setlow P.
PMID: 29259282
Sci Rep. 2017 Dec 19;7(1):17768. doi: 10.1038/s41598-017-18125-z.

Black silicon (bSi) wafers with a high density of high-aspect ratio nanopillars have recently been suggested to have mechanical bactericidal activity. However, it remains unclear whether bSi with the nanopillars can kill only growing bacterial cells or also dormant...

Cite
Ghosh S, Niu S, Yankova M, et al. Analysis of killing of growing cells and dormant and germinated spores of Bacillus species by black silicon nanopillars. Sci Rep. 2017;7(1):17768doi: 10.1038/s41598-017-18125-z.
Ghosh, S., Niu, S., Yankova, M., Mecklenburg, M., King, S. M., Ravichandran, J., Kalia, R. K., Nakano, A., Vashishta, P., & Setlow, P. (2017). Analysis of killing of growing cells and dormant and germinated spores of Bacillus species by black silicon nanopillars. Scientific reports, 7(1), 17768. https://doi.org/10.1038/s41598-017-18125-z
Ghosh, Sonali, et al. "Analysis of killing of growing cells and dormant and germinated spores of Bacillus species by black silicon nanopillars." Scientific reports vol. 7,1 (2017): 17768. doi: https://doi.org/10.1038/s41598-017-18125-z
Ghosh S, Niu S, Yankova M, Mecklenburg M, King SM, Ravichandran J, Kalia RK, Nakano A, Vashishta P, Setlow P. Analysis of killing of growing cells and dormant and germinated spores of Bacillus species by black silicon nanopillars. Sci Rep. 2017 Dec 19;7(1):17768. doi: 10.1038/s41598-017-18125-z. PMID: 29259282; PMCID: PMC5736721.
Copy Download .nbib Format: NLM
Influence of needle size and injection angle on the distribution pattern of facial soft tissue fillers.

Journal of cosmetic dermatology

Pavicic T, Mohmand HM, Yankova M, Schenck TL, Frank K, Freytag DL, Green JB, Hamade H, Cassuto D, Cotofana S.
PMID: 31282607
J Cosmet Dermatol. 2019 Jul 08; doi: 10.1111/jocd.13066. Epub 2019 Jul 08.

BACKGROUND: Soft tissue filler injections are performed using either sharp-tip needles or blunt-tip cannulas. Product can change planes in an uncontrolled manner during needle injections, potentially leading to unintentional intra-arterial placement. There is a paucity of data on the...

Cite
Pavicic T, Mohmand HM, Yankova M, et al. Influence of needle size and injection angle on the distribution pattern of facial soft tissue fillers. J Cosmet Dermatol. 2019;doi: 10.1111/jocd.13066.
Pavicic, T., Mohmand, H. M., Yankova, M., Schenck, T. L., Frank, K., Freytag, D. L., Green, J. B., Hamade, H., Cassuto, D., & Cotofana, S. (2019). Influence of needle size and injection angle on the distribution pattern of facial soft tissue fillers. Journal of cosmetic dermatology, . https://doi.org/10.1111/jocd.13066
Pavicic, Tatjana, et al. "Influence of needle size and injection angle on the distribution pattern of facial soft tissue fillers." Journal of cosmetic dermatology vol. (2019). doi: https://doi.org/10.1111/jocd.13066
Pavicic T, Mohmand HM, Yankova M, Schenck TL, Frank K, Freytag DL, Green JB, Hamade H, Cassuto D, Cotofana S. Influence of needle size and injection angle on the distribution pattern of facial soft tissue fillers. J Cosmet Dermatol. 2019 Jul 08; doi: 10.1111/jocd.13066. Epub 2019 Jul 08. PMID: 31282607.
Copy Download .nbib Format: NLM
Can we afford the NHS?.

Emergency nurse : the journal of the RCN Accident and Emergency Nursing Association

Iankova A.
PMID: 27718696
Emerg Nurse. 2006 Jul 01;14(4):11-13. doi: 10.7748/en.14.4.11.s17.

The structure, development and reorganisation of the NHS have been under close and almost constant scrutiny since it was devised nearly 60 years ago to provide free health care to the UK population. Over this time, it has been...

Cite
Iankova A. Can we afford the NHS?. Emerg Nurse. 2006;14(4):11-13doi: 10.7748/en.14.4.11.s17.
Iankova, A. (2006). Can we afford the NHS?. Emergency nurse : the journal of the RCN Accident and Emergency Nursing Association, 14(4), 11-13. https://doi.org/10.7748/en.14.4.11.s17
Iankova, Andriana. "Can we afford the NHS?." Emergency nurse : the journal of the RCN Accident and Emergency Nursing Association vol. 14,4 (2006): 11-13. doi: https://doi.org/10.7748/en.14.4.11.s17
Iankova A. Can we afford the NHS?. Emerg Nurse. 2006 Jul 01;14(4):11-13. doi: 10.7748/en.14.4.11.s17. PMID: 27718696.
Copy Download .nbib Format: NLM
Incorporation of Obstacle Hardening into Local Approach to Cleavage Fracture to Predict Temperature Effects in the Ductile to Brittle Transition Regime.

Materials (Basel, Switzerland)

Yankova MS, Jivkov AP, Patel R.
PMID: 33807626
Materials (Basel). 2021 Mar 05;14(5). doi: 10.3390/ma14051224.

Ductile-to-brittle-transition refers to observable change in fracture mode with decreasing temperature-from slow ductile crack growth to rapid cleavage. It is exhibited by body-centred cubic metals and presents a challenge for integrity assessment of structural components made of such metals....

Cite
Yankova MS, Jivkov AP, Patel R. Incorporation of Obstacle Hardening into Local Approach to Cleavage Fracture to Predict Temperature Effects in the Ductile to Brittle Transition Regime. Materials (Basel). 2021;14(5)doi: 10.3390/ma14051224.
Yankova, M. S., Jivkov, A. P., & Patel, R. (2021). Incorporation of Obstacle Hardening into Local Approach to Cleavage Fracture to Predict Temperature Effects in the Ductile to Brittle Transition Regime. Materials (Basel, Switzerland), 14(5), . https://doi.org/10.3390/ma14051224
Yankova, Maria S, et al. "Incorporation of Obstacle Hardening into Local Approach to Cleavage Fracture to Predict Temperature Effects in the Ductile to Brittle Transition Regime." Materials (Basel, Switzerland) vol. 14,5 (2021). doi: https://doi.org/10.3390/ma14051224
Yankova MS, Jivkov AP, Patel R. Incorporation of Obstacle Hardening into Local Approach to Cleavage Fracture to Predict Temperature Effects in the Ductile to Brittle Transition Regime. Materials (Basel). 2021 Mar 05;14(5). doi: 10.3390/ma14051224. PMID: 33807626; PMCID: PMC7961473.
Copy Download .nbib Format: NLM
Showing 1 to 11 of 11 entries